Skip to content
Screener

Zymeworks ZYME Total Current Assets

Total Current Assets at other companies

Pfizer logo
PfizerPFE
$42.82B-6.6%
Amgen logo
AmgenAMGN
$34.96B+30.8%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$93.75M+41.2%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$1.07B+106%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$679.23M-8.5%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$1.46B+313%

Other financials

Income statement

See full
Revenue$4.6M-90.6%
Operating income-$42.2M-6,158%
Net income-$45.0M-2,043%
EPS (diluted)-$0.62-2,167%

Balance sheet

See full
Cash & equivalents$179.4M+82.6%
Total debt$16.0M-14.3%
Total equity$80.4M-76.0%
Total assets$397.0M-2.8%

Cash flow

See full
Operating cash flow-$31.9M-365%
CapEx$216.0K+1,250%
Free cash flow-$31.9M-376%

Valuation

See full
Market cap$1.7B+83.2%
Enterprise value$1.54B+81.1%
P/S45.8×+38.3×

Profitability

See full
Operating margin-419%-518pp
Net margin-404%-489pp
FCF margin-324.7%-366pp

Returns & leverage

See full
Return on equity-72.3%-117pp
Debt / equity0.2×+0.1×
Current ratio6.3×-1.4×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: Zymeworks’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001937653-26-000047
AssetsJune 30,2026 / (unaudited)December 31,2025
Short-term marketable securities91,286187,640
Accounts receivable5,9304,638
Prepaid expenses and other current assets21,75915,332
Total current assets298,388248,767
Long-term marketable securities51,77741,787
Long-term prepaids and other assets2,2816,674
Deferred tax asset4,3544,707
Property and equipment, net13,95515,502

Item 1. Financial Statements

FAQ

What is Zymeworks's total current assets?
Zymeworks (ZYME) reported total current assets of $298.39M in Q2 2026.
How has Zymeworks's total current assets changed year-over-year?
Zymeworks's total current assets increased by 0.8% year-over-year, from $296.13M to $298.39M.
What is the long-term trend for Zymeworks's total current assets?
Over 4 years (2021 to 2025), Zymeworks's total current assets has grown at a -3.6% compound annual growth rate (CAGR), from $288.22M to $248.77M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about Zymeworks's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude